QQ客服 官方微博 反馈留言

浏览/检索结果: 共4条，第1-4条 帮助 限定条件 发表日期：2019     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Systematic review and meta-analysis of prevalence of dermatological toxicities associated with vemurafenib treatment in patients with melanoma 期刊论文 CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2019, 卷号: 44, 期号: 3 作者:  Chen, P.;  Chen, F.;  Zhou, B. 收藏  |  浏览/下载：1/0  |  提交时间：2019/12/05 Resistance mechanism of the oncogenic beta 3-alpha C deletion mutation in BRAF kinase to dabrafenib and vemurafenib revealed by molecular dynamics simulations and binding free energy calculations 期刊论文 CHEMICAL BIOLOGY & DRUG DESIGN, 2019, 卷号: 93, 期号: 2, 页码: 177-187 作者:  Niu, Yuzhen;  Zhang, Yan;  Yao, Xiaojun 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/11 binding free energy calculation  BRAF inhibitors  drug resistance  molecular dynamics simulation  residue interaction network analysis   Signal transducer and activator of transcription 3 inhibition enhances vemurafenib sensitivity in colon cancers harboring the BRAF mutation 期刊论文 Journal of Cellular Biochemistry, 2019, 卷号: Vol.120 No.4, 页码: 5315-5325 作者:  Kai Wang;  Yanrong Li;  Na Song;  Xiaofang Che;  Kezuo Hou 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/17 apoptosis  colon  cancer  proliferation  signal  transducer  and  activator  of  transcription  3  vemurafenib   Acquired and intrinsic resistance to vemurafenib in BRAF(v600e)-driven melanoma brain metastases 会议论文 Annual Meeting of the American-Association-for-Cancer-Research (AACR), MAR 29-APR 03, 2019 作者:  de Gooijer, Mark C.;  Zhang, Ping;  Buil, Levi C.;  Freriks, Stephan;  Li, Gang 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/31